主品牌韧性增长+户外品牌持续高增，加速 海外市场布局 核心观点 盈利预测与投资建议 ⚫ 根据年报，我们调整了 25-26 年的盈利预测（上调了收入，下调了毛利率）并引入了 27 年的盈利预测，预计 2025-2027 年每股收益分别为 4.82、5.54 和 6.24 元（原 25- 26 为 4.92 和 5.64 元），参考可比公司，我们维持公司 2025 年 21 倍 PE 估值，对应 目标价 108.31 港币（1 人民币=1.07 港币），维持"买入"评级。 风险提示：流行风尚变化、市场竞争加剧、全球运动服饰消费减速等 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 62,356 | 70,826 | 78,370 | 86,449 | 95,412 | | 同比增长 (%) | 16.2% | 13.6% | 10.7% | 10.3% | 10.4% | | 营业利润(百万元) | 15,367 | 16,595 | 18,525 | ...

Investment Rating - The report maintains a "Buy" rating for the company with a target price not specified [4] Core Viewpoints - The main brand, Xtep, shows steady performance with a revenue increase of 3% to 12.3 billion, while professional sports revenue (including Saucony) surged by 57% to 1.3 billion [1] - The overall revenue for 2024 is projected at 13.6 billion, reflecting a 7% year-on-year growth [1] - The company is focusing on a Direct-to-Consumer (DTC) strategy to enhance brand loyalty and customer retention, with plans to reclaim distribution rights for 400-500 stores by 2026 [3] - The running trend in China continues to grow, with Xtep achieving the highest wearing rate in major marathons, solidifying its position as a leading running brand [2] Summary by Sections Financial Performance - Total revenue for 2024 is 13.6 billion, up 7% year-on-year; main brand revenue is 12.3 billion, up 3%, and professional sports revenue is 1.3 billion, up 57% [1] - Footwear revenue is 8.1 billion (59% of total), up 16%, while apparel revenue is 5.2 billion, down 6% [1] - The overall gross margin for 2024 is 43%, an increase of 1.4 percentage points [1] - Net profit attributable to shareholders is projected at 1.2 billion, a 20% increase [1] Market Position and Strategy - The company operates 6,382 adult brand stores and 1,584 children's stores in China, with plans to enhance its DTC strategy [3] - Saucony is positioned as a secondary growth driver, ranking among the top three in marathon shoe wearing rates [2] Future Outlook - Revenue forecasts for 2025-2027 are 14.7 billion, 15.8 billion, and 17 billion respectively, with net profit estimates of 1.36 billion, 1.52 billion, and 1.69 billion [4]

纺织服装 安踏体育（02020.HK） 买入-A(维持) 2024 年稳健增长，户外运动品牌营收突破百亿 2025 年 3 月 20 日 公司研究/公司快报 公司近一年市场表现 事件描述 3 月 19 日，公司发布 2024 年年报，2024 年，公司实现营收 708.26 亿元，同比增 长 13.6%，实现归母净利润 155.96 亿元，同比增长 52.4%。拟派末期股息 118 港分/股， 全年派息率 51.4%（剔除 Amer Sports 上市事项及 Amer Sports 配售事项权益摊薄所致 的非现金会计利得）。 事件点评 资料来源：最闻，山西证券研究所 市场数据：2025 年 3 月 19 日 收盘价（港元）： 97.900 年内最高/最低（港元）： 107.50/65.550 流通 A 股/总股本（亿股）： 28.07/28.07 流通 A 股市值（亿港元）： 2,748.26 2024 年公司营收增长稳健，电商渠道增速快于线下。营收端，2024 年，公司实现 营收 708.26 亿元，同比增长 13.6%，其中公司电商渠道收入同比增长 21.8%，占集团收 入比重上升 2.3pct 至 35 ...

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company reported a net profit of 1.24 billion RMB for FY2024, marking a 20.2% year-on-year increase, achieving a historical high [5] - The main brand's revenue grew steadily, with professional sports showing strong performance, particularly with a 57.2% increase in revenue from the professional sports segment [5] - The company is focusing on direct-to-consumer (DTC) channel transformation to enhance long-term competitiveness [5] Financial Data and Profit Forecast - FY2023 revenue was 143.46 billion RMB, with a projected revenue of 146.36 billion RMB for FY2025, reflecting an 8% growth [4] - The net profit for FY2023 was 1.03 billion RMB, expected to rise to 1.37 billion RMB by FY2025, indicating a 10% growth [4] - The gross margin is projected to improve from 42% in FY2023 to 45% by FY2027 [4] Brand and Channel Performance - The main brand's revenue accounted for 90.8% of total revenue, with a slight decrease in gross margin to 41.8% [5] - Online sales grew approximately 20%, with new platforms like Douyin and Xiaohongshu seeing over 80% growth [5] - The company operates 6,382 adult clothing stores, with a net decrease of 189 stores, while children's stores numbered 1,584, with a net decrease of 119 stores [5] Profitability and Cash Flow - The gross margin improved to 43.2%, with a net profit margin of 9.1% [5] - Inventory turnover days decreased by 22 days to 68 days, indicating improved efficiency [5] - Operating cash flow remained stable at 1.228 billion RMB, with cash and cash equivalents totaling 3 billion RMB [5]

Investment Rating - The report assigns a rating of "Buy" for the company, expecting a relative increase of 5% to 15% compared to the CSI 300 index over the next six months [19][18]. Core Views - The company's beer business is steadily progressing towards high-end products, while the white liquor segment is experiencing counter-cyclical growth [1][10]. - The company achieved total revenue of 38.635 billion yuan in 2024, a year-on-year decrease of 0.8%, and a net profit of 4.739 billion yuan, down 8% year-on-year [3][9]. - The high-end beer sales grew by over 9% year-on-year, with Heineken seeing close to 20% growth, and the overall product structure is upgrading with mid-range and above beer sales exceeding 50% for the first time [4][5]. Summary by Sections Financial Performance - In 2024, the company reported total revenue of 38.635 billion yuan and a net profit of 4.739 billion yuan, with EBIT at 4.567 billion yuan, reflecting a slight increase of 0.2% year-on-year [3][9]. - The overall gross margin improved to 42.6%, up 1.3 percentage points year-on-year, with the beer segment's gross margin at 41.1% [6][9]. Sales and Growth - The beer sales volume in 2024 was 10.874 million tons, with a price of 3,355 yuan per ton, showing a decrease of 2.5% in volume but an increase of 1.5% in price year-on-year [4][5]. - The white liquor business generated revenue of 2.149 billion yuan, up 4% year-on-year, with a gross margin increase of 5.6 percentage points to 68.5% [5][6]. Future Projections - Revenue growth is projected at 6% for 2025, 5% for 2026, and 4% for 2027, with net profit growth expected at 9% for 2025 and 8% for the following years [9][12]. - The estimated earnings per share (EPS) are projected to be 1.59 yuan for 2025, 1.72 yuan for 2026, and 1.86 yuan for 2027 [9][12].

Investment Rating - The report assigns an "Outperform" rating for the company [2] Core Insights - The company has shown continuous improvement in profitability, with both organic and external growth strategies being effectively implemented [5] - The revenue for 2024 is projected to be 13,074 million HKD, reflecting a year-on-year growth of 10.5% [6] - The net profit for 2024 is expected to reach 853.74 million HKD, indicating a significant year-on-year increase of 42.6% [6] - The report highlights the company's strong performance in both import and export of tobacco products, with notable growth in various segments [6] Financial Performance Summary - Revenue and Profit Forecasts: - 2023: Revenue of 11,836.22 million HKD, Net Profit of 598.77 million HKD - 2024: Revenue of 13,074.24 million HKD, Net Profit of 853.74 million HKD - 2025E: Revenue of 14,590.45 million HKD, Net Profit of 965.40 million HKD - 2026E: Revenue of 15,989.09 million HKD, Net Profit of 1,124.04 million HKD - 2027E: Revenue of 17,346.28 million HKD, Net Profit of 1,287.66 million HKD [6][10] - Earnings Per Share (EPS) is projected to grow from 1.23 HKD in 2024 to 1.86 HKD by 2027 [10] - The gross margin is expected to improve from 10.54% in 2024 to 11.59% in 2027, driven by a higher proportion of high-margin products [10] Business Segment Performance - Import Business: - Revenue from tobacco leaf imports is projected to be 8,254.25 million HKD in 2024, with a growth rate of 2.17% [9] - Export Business: - Tobacco leaf export revenue is expected to reach 2,061.54 million HKD in 2024, with a growth rate of 24.78% [9] - Cigarette export revenue is forecasted at 1,573.64 million HKD in 2024, with a growth rate of 30.19% [9] - New Tobacco Products: - Revenue from new tobacco products is projected to be 135.18 million HKD in 2024, with a growth rate of 4.00% [9] Valuation and Price Target - The report estimates a reasonable valuation range for the company at 28.00 to 29.40 HKD for 2025, based on a price-to-earnings (PE) ratio of 20 to 21 times [6]

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative increase of over 15% in the stock price compared to the benchmark index within the next 6 to 12 months [8]. Core Insights - The company achieved a revenue of 135.77 billion yuan in 2024, representing a year-on-year growth of 6.5% after excluding the divested K&P business. The net profit attributable to shareholders was 12.38 billion yuan, with a year-on-year increase of 20.2%, aligning with expectations [4]. - The main brand, Xtep, reported a revenue of 123.27 billion yuan in 2024, growing by 3.2%. The online e-commerce segment saw approximately 20% growth, accounting for over 30% of total revenue, with emerging platforms like Douyin experiencing over 80% growth [4]. - The professional sports segment, including Saucony, achieved a revenue of 1.25 billion yuan in 2024, marking a significant year-on-year increase of 57.2%. Saucony's revenue surpassed 1 billion yuan, with improved profitability [4]. - The company plans to enhance its Direct-to-Consumer (DTC) strategy, aiming to recover distribution rights for approximately 400 to 500 Xtep stores by late 2025 and 2026 [4]. Financial Performance Summary - Revenue projections for the company are as follows: 2023A at 14,346 million yuan, 2024A at 13,577 million yuan, 2025E at 14,531 million yuan, 2026E at 15,685 million yuan, and 2027E at 16,831 million yuan [2]. - The net profit attributable to shareholders is forecasted to be 1,030 million yuan in 2023A, increasing to 1,672 million yuan by 2027E, with a consistent growth rate of around 10% [2]. - The company's gross margin improved to 43.2% in 2024, with a net margin of 9.1%, reflecting a year-on-year increase of 1.0 percentage points [4]. Valuation Metrics - The report indicates a Price-to-Earnings (P/E) ratio forecast of 13.1 for 2023A, decreasing to 8.1 by 2027E, suggesting an attractive valuation as earnings grow [2]. - The Price-to-Book (P/B) ratio is projected to decline from 1.5 in 2023A to 1.0 in 2027E, indicating a strengthening balance sheet relative to market valuation [2].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a revenue of 11.799 billion and a net profit of 1.303 billion for 2024, reflecting a year-on-year change of +5% and -21% respectively. In the second half of 2024, revenue and net profit were 6.761 billion and 620 million, showing a year-on-year increase of +11% and a decrease of -33% respectively [2][4]. - The core business of the company is recovering growth, with the HNB (Heated Not Burned) segment showing potential as a future growth driver. The company has received positive feedback from consumers and British American Tobacco in Serbia [6][4]. - The company is focusing on expanding its product matrix with new launches and enhancing its market share in the open product segment through its brand VAPORESSO [6][4]. Revenue Summary - The company's revenue from the TOB (Business to Business) segment in the second half of 2024 increased by 11%, with contributions from various regions: +5% from the US, +17% from mainland China, and +14% from Europe and other regions. The revenue breakdown shows a decline in disposable products but growth in the HNB and APV (Advanced Personal Vaporizer) segments [6][4]. - The TOC (Business to Consumer) segment also saw a revenue increase of 13% in the second half of 2024, supported by the establishment of localized marketing teams and online store management systems [6][4]. Profitability Summary - The company's gross margin decreased by 3.9 percentage points to 37.0% in the second half of 2024, primarily due to changes in product sales structure. The net profit dropped by 33%, influenced by increased sales and R&D expenses [6][4]. - The company is investing heavily in marketing and R&D, particularly in the fields of medical vaporization and heated not burned products, which is expected to impact profitability in the short term but may yield long-term benefits [6][4]. Long-term Outlook - The company aims for a market capitalization target of 300 to 500 billion, with significant growth potential in the HNB business and a positive trend in traditional business recovery. The company is committed to long-term development and increasing investment in HNB and medical vaporization R&D [6][4]. - The company has launched the Glo Hilo product in collaboration with British American Tobacco, which has shown promising feedback in terms of heating time, taste, and design, indicating a competitive edge against existing products like IQOS [6][4]. - The company is also progressing in the clinical development of drug-device combination products for respiratory diseases, which is expected to contribute significantly to revenue in the future [6][4].

Investment Rating - The report assigns a rating of "Buy" for the company, expecting a relative increase of 5% to 15% compared to the CSI 300 index over the next six months [19]. Core Insights - The company's beer business is steadily progressing towards high-end products, while the white liquor segment is experiencing counter-cyclical growth [1][10]. - For 2024, the company achieved total revenue of 38.635 billion yuan, a year-on-year decrease of 0.8%, and a net profit attributable to shareholders of 4.739 billion yuan, down 8% year-on-year [3][9]. - The company is expected to see revenue growth rates of 6%, 5%, and 4% for 2025, 2026, and 2027 respectively, with net profit growth rates of 9%, 8%, and 8% for the same years [6][9]. Summary by Sections Beer Business - In 2024, the company sold 10.874 million tons of beer at a price of 3,355 yuan per ton, reflecting a year-on-year decrease of 2.5% in volume but an increase of 1.5% in price. High-end beer sales grew over 9% year-on-year, with Heineken close to 20% growth [4][5]. - The company is expanding its distribution channels, including partnerships with instant retail platforms, resulting in over 30% growth in online GMV [4]. White Liquor Business - The white liquor segment generated revenue of 2.149 billion yuan in 2024, a year-on-year increase of 4%, with a gross margin improvement of 5.6 percentage points to 68.5% [5]. - The brand "摘要" saw a sales increase of 35%, contributing over 70% to the white liquor revenue, driven by strong brand building and inventory management [5]. Financial Performance - The overall gross margin for the company improved to 42.6%, up 1.3 percentage points year-on-year. The EBITDA margin was 20.9%, reflecting a 0.7 percentage point increase [6]. - The company plans to distribute a total dividend of 0.76 yuan per share for 2024, with a payout ratio of 52% [6]. Future Projections - Revenue projections for 2025, 2026, and 2027 are 40.904 billion yuan, 42.758 billion yuan, and 44.588 billion yuan respectively, with corresponding net profits of 5.145 billion yuan, 5.574 billion yuan, and 6.031 billion yuan [9][12].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][10]. Core Views - The report highlights a turning point in the company's atomization business and expresses optimism about the future of its HNB (Heated Not Burned) business [1]. - The company reported a total revenue of 11.8 billion RMB for 2024, representing a year-on-year increase of 5.3%. However, net profit decreased by 20.8% to 1.3 billion RMB, with a net profit margin of 11.0% [4][6]. Summary by Sections Financial Performance - In 2024, the company's revenue was 11.8 billion RMB, with a gross margin of 37.4%, down 1.3 percentage points from the previous year. The net profit was 1.3 billion RMB, reflecting a decrease of 20.8% year-on-year [4][6][7]. - The company declared a final dividend of 0.05 HKD per share as of December 31, 2024 [4]. Revenue Breakdown - The self-owned brand business saw significant growth, with revenue reaching 2.48 billion RMB, up 34.0% year-on-year. Notably, revenue from Europe and other regions for electronic atomization products was 2.02 billion RMB, up 37.2% [6]. - Revenue from enterprise client business was 9.32 billion RMB, slightly down by 0.3%. The report anticipates that increased regulatory enforcement in the U.S. will enhance market share for compliant products [6]. Research and Development - The company maintained a high R&D expenditure, amounting to 1.57 billion RMB, which is 13.3% of total revenue. This includes 1.03 billion RMB for electronic nicotine delivery systems [6][7]. - Sales and distribution expenses rose significantly by 74.7% to 920 million RMB, attributed to increased marketing efforts for self-owned brands globally [6]. Future Projections - The company is projected to achieve revenues of 13.13 billion RMB in 2025, 15.27 billion RMB in 2026, and 17.54 billion RMB in 2027, with growth rates of 11%, 16%, and 15% respectively [9][10]. - Expected net profits for 2025, 2026, and 2027 are 1.63 billion RMB, 2.15 billion RMB, and 2.64 billion RMB, with growth rates of 25%, 32%, and 23% respectively [9][10].